Skip to content
★ Sign in to follow
JR

James R. Piggott PhD

Lexicon Pharmaceuticals, Inc.
Total declarations
18
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (17 ops.)
€140k

Latest filing published 17 May 2007 for Lexicon Pharmaceuticals, INC., €2,514.

Insider track record

Disclosed buys
0
Disclosed sells
17
Signal history

No signal scores available.

James R. Piggott PhD: trading record in brief

James R. Piggott PhD discloses dealings in Lexicon Pharmaceuticals, Inc. to SEC (Form 4). In total, 18 filings cover trades dated from 23 March 2006 to 15 May 2007.

No open-market purchase appears, only 17 sales worth €140k. The rest of the record consists of 1 option exercise. 2007 to date brings no purchases and 1 sale.

The newest entry dates from 17 May 2007: an open-market sale of €2,514, in Lexicon Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to James R. Piggott PhD

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations18 total

18 of 18 declarations